Efficacy of <scp>GLP</scp> ‐1 receptor agonists in patients with obesity and heart failure with preserved ejection fraction: A systematic review and meta‐analysis of randomised controlled trials

Simple item page
dc.contributor.authorJuan Armando Talavera
dc.contributor.authorLarissa Teixeira
dc.contributor.authorBenjamin Klein
dc.contributor.authorRaiane Rosa de Souza Lopes
dc.contributor.authorDaniela Urina‐Jassir
dc.contributor.authorDenilsa Navalha
dc.contributor.authorBranco Gonzalo Matias Bettinotti
dc.contributor.authorNicole Fernandez
dc.contributor.authorMiguel Urina‐Triana
dc.contributor.authorFrancine K. Welty
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:04:13Z
dc.date.available2026-03-22T21:04:13Z
dc.date.issued2025
dc.descriptionCitaciones: 1
dc.description.abstractGLP-1 RAs significantly reduced heart failure events, improved KCCQ-CSS score, reduced body weight, and improved 6MWD compared to placebo.
dc.identifier.doi10.1111/dom.70102
dc.identifier.urihttps://doi.org/10.1111/dom.70102
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85749
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofDiabetes Obesity and Metabolism
dc.sourceMount Sinai Medical Center
dc.subjectMedicine
dc.subjectHeart failure
dc.subjectHeart failure with preserved ejection fraction
dc.subjectInternal medicine
dc.subjectCardiology
dc.subjectObesity
dc.subjectClinical trial
dc.subjectAgonist
dc.subjectReceptor
dc.subjectRandomized controlled trial
dc.titleEfficacy of <scp>GLP</scp> ‐1 receptor agonists in patients with obesity and heart failure with preserved ejection fraction: A systematic review and meta‐analysis of randomised controlled trials
dc.typereview

Files

Collections

Artículo Científico Publicado